Kraig Biocraft Laboratories, Inc. (KBLB) Stock Price & Analysis
Kraig Biocraft Laboratories, Inc. (KBLB) rose 1.87% to USD 0.08 as of September 9, 2026 at 00:31 UTC, according to Nexqual real-time market data.
KBLB last closed at USD 0.08; the session ranged USD 0.08–0.08 on volume of 348,736 shares. Market capitalization is $91.12M, with a 52-week range of USD 0.07–0.16 (OQB). Source: Nexqual, September 9, 2026 at 00:31 UTC.
Key Statistics (as of September 9, 2026 at 00:31 UTC)
| Price | USD 0.08 |
|---|---|
| Change | ▲ 1.87% (up) |
| Previous Close | USD 0.08 |
| Open | USD 0.08 |
| Day Range | USD 0.08 – 0.08 |
| 52-Week Range | USD 0.07 – 0.16 |
| Volume | 348,736 shares |
| Market Cap | $91.12M |
| Exchange | OQB |
Technical Analysis (KBLB)
Nexqual's technical model rates KBLB "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 9, 2026 at 00:31 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.28 (neutral) |
| vs SMA50 | Below (USD 0.09) |
| MACD | -0 (negative) |
Analyst Ratings (KBLB)
Wall Street analysts rate KBLB "None", per Nexqual as of September 9, 2026 at 00:31 UTC.
| Consensus Rating | None |
|---|
Earnings (KBLB)
Source: Nexqual, September 9, 2026 at 00:31 UTC.
Financials & Fundamentals (KBLB)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.33 |
| Total Cash | $3.39M |
| Total Debt | $1.69M |
| Free Cash Flow | $-689,147 |
Source: Nexqual, September 9, 2026 at 00:31 UTC.
Financial Health Score (KBLB)
Nexqual rates Kraig Biocraft Laboratories, Inc.'s overall financial health "Weak" across five dimensions, as of September 9, 2026 at 00:31 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $3M cash vs $2M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$2M |
| Efficiency | Mixed — No data |
Ownership (KBLB)
| Insider Ownership | +18.59% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 1.12B |
| Float | 852.48M |
Source: Nexqual, September 9, 2026 at 00:31 UTC.
Leadership (KBLB)
Kraig Biocraft Laboratories, Inc. is led by Kim Kraig Thompson (age 64), Founder, CEO, President, CFO, Corporate Secretary & Director, per Nexqual as of September 9, 2026 at 00:31 UTC.
| Founder, CEO, President, CFO, Corporate Secretary & Director | Kim Kraig Thompson (age 64) |
|---|---|
| Chief Operating Officer | Jonathan R. Rice (age 45) |
| President of Prodigy Silk | Kenneth Le (age 61) |
From Kraig Biocraft Laboratories, Inc.'s Latest SEC 10-K Filing (filed 2026-03-30)
Key Strengths & Strategy (as disclosed to the SEC)
- Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States.
- The company's primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk.
- Its products are used in performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics, and other applications; and military and police for its ballistic protection.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNWV | SANUWAVE Health, Inc. | USD 4.16 | ▼ 6.52% |
| EVHO | Evercore Holdings, Inc. | USD 0 | ▲ 19.05% |
| CDIX | Cardiff Lexington Corporation | USD 0.12 | ▼ 42% |
| CNNA | Cann American Corp. | USD 0.01 | ▲ 0% |
| SMME | SmartMetric, Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 00:31 UTC. This page is informational and not investment advice.